CVS Health stock is trading -25.62% below its average target price of $90.16 after marking a 1.2% during today's morning session. Analysts are giving the large-cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $76.0 to $110.0 per share.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.1%. The stock's short ratio is 1.96. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 79.9%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Vanguard Group Inc | 9% | 116,676,882 | $7,824,351,422 |
| 2023-06-30 | Blackrock Inc. | 7% | 93,734,850 | $6,285,858,812 |
| 2023-06-30 | State Street Corporation | 4% | 55,877,387 | $3,747,137,435 |
| 2023-06-30 | Morgan Stanley | 3% | 33,253,424 | $2,229,974,532 |
| 2023-06-30 | Capital World Investors | 2% | 30,490,802 | $2,044,713,107 |
| 2023-06-30 | Geode Capital Management, LLC | 2% | 23,325,287 | $1,564,193,689 |
| 2023-06-30 | FMR, LLC | 2% | 21,292,797 | $1,427,894,914 |
| 2023-06-30 | Invesco Ltd. | 1% | 17,002,487 | $1,140,186,736 |
| 2023-06-30 | Bank of America Corporation | 1% | 16,551,119 | $1,109,917,999 |
| 2023-06-30 | Dodge & Cox Inc | 1% | 16,024,422 | $1,074,597,700 |
